{
    "abstractText": "COPYRIGHT \u00a9 2023 Wang, Li, Li, Zhao, Li, Sun, Li, Zhao, Zhao, He, Guo, Ge, Wang, Ding, Liu, Min and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. TYPE Correction PUBLISHED 20 January 2023 DOI 10.3389/fimmu.2023.1134847",
    "authors": [
        {
            "affiliations": [],
            "name": "Riccardo Dolcetti"
        },
        {
            "affiliations": [],
            "name": "Peter MacCallum"
        },
        {
            "affiliations": [],
            "name": "Xiaonan Zhang"
        },
        {
            "affiliations": [],
            "name": "Tao Wang"
        },
        {
            "affiliations": [],
            "name": "Tianye Li"
        },
        {
            "affiliations": [],
            "name": "Baiqing Li"
        },
        {
            "affiliations": [],
            "name": "Jiahui Zhao"
        },
        {
            "affiliations": [],
            "name": "Zhi Li"
        },
        {
            "affiliations": [],
            "name": "Mingyi Sun"
        },
        {
            "affiliations": [],
            "name": "Yan Li"
        },
        {
            "affiliations": [],
            "name": "Yanjiao Zhao"
        },
        {
            "affiliations": [],
            "name": "Shidi Zhao"
        },
        {
            "affiliations": [],
            "name": "Weiguang He"
        },
        {
            "affiliations": [],
            "name": "Xiao Guo"
        },
        {
            "affiliations": [],
            "name": "Rongjing Ge"
        },
        {
            "affiliations": [],
            "name": "Lian Wang"
        },
        {
            "affiliations": [],
            "name": "Dushan Ding"
        },
        {
            "affiliations": [],
            "name": "Saisai Liu"
        },
        {
            "affiliations": [],
            "name": "Simin Min"
        }
    ],
    "id": "SP:1a389718363477dd53ed13d76b3874f32cea9bf2",
    "references": [],
    "sections": [
        {
            "text": "Frontiers in Immunology"
        },
        {
            "heading": "OPEN ACCESS",
            "text": ""
        },
        {
            "heading": "EDITED AND REVIEWED BY",
            "text": "Riccardo Dolcetti, Peter MacCallum Cancer Centre, Australia\n*CORRESPONDENCE Xiaonan Zhang\nzhangxn@bbmc.edu.cn"
        },
        {
            "heading": "SPECIALTY SECTION",
            "text": "This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology\nRECEIVED 31 December 2022 ACCEPTED 12 January 2023 PUBLISHED 20 January 2023"
        },
        {
            "heading": "CITATION",
            "text": "Wang T, Li T, Li B, Zhao J, Li Z, Sun M, Li Y, Zhao Y, Zhao S, He W, Guo X, Ge R, Wang L, Ding D, Liu S, Min S and Zhang X (2023) Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures. Front. Immunol. 14:1134847. doi: 10.3389/fimmu.2023.1134847"
        },
        {
            "heading": "COPYRIGHT",
            "text": "\u00a9 2023 Wang, Li, Li, Zhao, Li, Sun, Li, Zhao, Zhao, He, Guo, Ge, Wang, Ding, Liu, Min and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.\nTYPE Correction PUBLISHED 20 January 2023 DOI 10.3389/fimmu.2023.1134847\nCorrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures\nTao Wang1, Tianye Li1, Baiqing Li2, Jiahui Zhao1, Zhi Li1, Mingyi Sun1, Yan Li3, Yanjiao Zhao1, Shidi Zhao3, Weiguang He4, Xiao Guo5, Rongjing Ge3, Lian Wang3, Dushan Ding3, Saisai Liu3, Simin Min3 and Xiaonan Zhang1,3*\n1College of Life and Health Sciences, Northeastern University, Shenyang, China, 2Department of Immunology, Bengbu Medical College, Bengbu, China, 3Department of Pathophysiology, Bengbu Medical College, Bengbu, China, 4Department of Radiology, Tian Jin Fifth\u2019s Central Hospital, Tianjin, China, 5College of Pharmacy, Beihua University, Jilin, China"
        },
        {
            "heading": "KEYWORDS",
            "text": "immune subtype, tumor microenvironment, immune escape, immunotherapy, breast cancer\nA Corrigendum on\nImmunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures\nby Wang T, Li T, Li B, Zhao J, Li Z, Sun M, Li Y, Zhao Y, Zhao S, He W, Guo X, Ge R, Wang L, Ding D, Liu S, Min S and Zhang X (2022) Front. Immunol. 13:805184. doi: 10.3389/fimmu.2022.805184\nIn the published article, there was an error in the IHC images of Figure 5B as published.\nFour repeat IHC images were displayed cursorily. The corrected Figure 5B and its caption\n\u201cConstruction of the immune biological signature. (A) DEGs were used to construct the\nimmune biological signature. (B) Representative immunohistochemical images of infiltrated\nimmune cells in Bengbu cohort between high- and low- ITBscore groups. (C) Kaplan-Meier\ncurves for patients in the BRCA cohort divided into high and low ITBscore subgroups. (D)\nAlluvial diagram indicating immune subtypes in groups with different BRCA subtypes (basal,\nfrontiersin.org01\nWang et al. 10.3389/fimmu.2023.1134847\nHer2, LumA, LumB, and normal), ITBscores, and survival outcomes.\n(E) Prognostic value of the ITBscore and classic clinicopathological\ncovariates in the high/low ITBscore subgroups. (F) Distribution of the\nITBscore among TCGA-BRCA molecular subtypes. \u201c appear below.\nThe authors apologize for this error and state that this does not\nchange the scientific conclusions of the article in any way. The\noriginal article has been updated.\nFrontiers in Immunology 02\nPublisher\u2019s note\nAll claims expressed in this article are solely those of the authors\nand do not necessarily represent those of their affiliated organizations,\nor those of the publisher, the editors and the reviewers. Any product\nthat may be evaluated in this article, or claim that may be made by its\nmanufacturer, is not guaranteed or endorsed by the publisher.\nB\nC D\nE F\nA\nFIGURE 1 Construction of the immune biological signature. (A) DEGs were used to construct the immune biological signature. (B) Representative immunohistochemical images of infiltrated immune cells in Bengbu cohort between high- and low- ITBscore groups. (C) Kaplan-Meier curves for patients in the BRCA cohort divided into high and low ITBscore subgroups. (D) Alluvial diagram indicating immune subtypes in groups with different BRCA subtypes (basal, Her2, LumA, LumB, and normal), ITBscores, and survival outcomes. (E) Prognostic value of the ITBscore and classic clinicopathological covariates in the high/low ITBscore subgroups. (F) Distribution of the ITBscore among TCGA-BRCA molecular subtypes.\nfrontiersin.org"
        }
    ],
    "title": "Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures",
    "year": 2023
}